Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
Titel:
Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
Auteur:
Kintu, Kenneth Malaba, Thokozile R Nakibuka, Jesca Papamichael, Christiana Colbers, Angela Byrne, Kelly Seden, Kay Hodel, Eva Maria Chen, Tao Twimukye, Adelline Byamugisha, Josaphat Reynolds, Helen Watson, Victoria Burger, David Wang, Duolao Waitt, Catriona Taegtmeyer, Miriam Orrell, Catherine Lamorde, Mohammed Myer, Landon Khoo, Saye